Héctor Fabio Mueses-Marín

Learn More
HIV testing rates remain very low in Colombia, with only 20% of individuals at risk ever tested. In order to tackle this issue, the Corporacion de Lucha Contra el Sida (CLS) has implemented a multidisciplinary, provider-initiated, population-based HIV testing/counselling strategy named BAFI. In this report, we describe the experience of CLS at reaching(More)
INTRODUCTION Little has been published in Colombia on HIV drug resistance in patients taking antiretroviral treatment (ART). Currently, the Colombian guidelines do not recommend the use of genotypic antiretroviral resistance tests (GART) for treatment-naive patients or for those experiencing a first therapeutic failure. OBJECTIVE To determine the(More)
BACKGROUND Generic drug policies are often associated with concerns about the quality and effectiveness of these products. Phase IV clinical trials may be a suitable design to assess the effectiveness and safety of generic drugs. The objective of this study was to describe the effectiveness and the safety of the generic abacavir/lamivudine and efavirenz in(More)
Background: Morbidity and mortality among HIV+ patients have decreased significantly with antiretroviral therapy; paradoxically, nutritional problems in HIV+ people have multiplied. Aim: To determine knowledge, attitudes and practices towards nutrition, and its relation with the prevalence of metabolic syndrome among HIV+ patients receiving antiretroviral(More)
  • 1